- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
United Therapeutics (UTHR)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 1.34 bn | 1.34 bn | 1.34 bn | 1.34 bn | 1.34 bn | 1.34 bn |
| Cash burn (monthly) | 84.33 mm | 17.82 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 363.04 mm | 76.70 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 977.06 mm | 1.26 bn | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 11.6 | 70.9 | n/a | n/a | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 663 |
| Opened positions | 107 |
| Closed positions | 59 |
| Increased positions | 264 |
| Reduced positions | 202 |
| 13F shares | Current |
|---|---|
| Total value | 14.45 tn |
| Total shares | 46.19 mm |
| Total puts | 103.86 k |
| Total calls | 122.50 k |
| Total put/call ratio | 0.8 |
| Largest owners | Shares | Value |
|---|---|---|
| BLK BlackRock | 5.36 mm | $1.89 tn |
| Vanguard | 4.44 mm | $1.57 tn |
| Avoro Capital Advisors | 2.76 mm | $973.94 bn |
| Wellington Management | 2.46 mm | $869.36 bn |
| Integrated Core Strategies | 2.24 mm | $175.63 mm |
| STT State Street | 2.20 mm | $776.30 bn |
| Renaissance Technologies | 2.09 mm | $737.22 bn |
| FMR | 1.47 mm | $519.17 bn |
| Geode Capital Management | 1.14 mm | $401.18 bn |
| Aqr Capital Management | 975.44 k | $344.18 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Feb 26 | Mahon Paul A | Common Stock | Sell | Dispose S | No | Yes | 485.5179 | 675 | 327.72 k | 36,781 |
| 5 Feb 26 | Mahon Paul A | Common Stock | Sell | Dispose S | No | Yes | 484.9159 | 934 | 452.91 k | 37,456 |
| 5 Feb 26 | Mahon Paul A | Common Stock | Sell | Dispose S | No | Yes | 483.9242 | 2,748 | 1.33 mm | 38,390 |
| 5 Feb 26 | Mahon Paul A | Common Stock | Sell | Dispose S | No | Yes | 482.5675 | 1,103 | 532.27 k | 41,138 |
| 5 Feb 26 | Mahon Paul A | Common Stock | Sell | Dispose S | No | Yes | 481.9338 | 2,363 | 1.14 mm | 42,241 |
| 5 Feb 26 | Mahon Paul A | Common Stock | Sell | Dispose S | No | Yes | 480.9191 | 477 | 229.40 k | 44,604 |
| 5 Feb 26 | Mahon Paul A | Common Stock | Option exercise | Acquire M | No | Yes | 146.03 | 8,300 | 1.21 mm | 45,081 |
| 5 Feb 26 | Mahon Paul A | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 146.03 | 8,300 | 1.21 mm | 50,100 |
| 3 Feb 26 | Jan Malcolm | Common Stock | Sell | Dispose S | No | Yes | 474.23 | 50 | 23.71 k | 270 |
| 2 Feb 26 | Benkowitz Michael | Common Stock | Sell | Dispose S | Yes | Yes | 470.9524 | 7,875 | 3.71 mm | 0 |